Purity01
HPLC purity
Chromatographic analysis of sample purity and its impurity profile. Purity is not the amount of compound in a vial.
Certificates of Analysis
Published sample results. Clear testing scope. A more complete picture, coming soon.
Expanded testing · Coming soon
Beyond purity.
More insight into your sample.
Apex is preparing a nine-panel testing program with Apollo Analytical. Explore the laboratory's published services below, and review the sample-specific reports already available today.
Inside the planned testing scope
These are the nine individual services listed on Apollo's pricing page, not a laboratory-confirmed nine-assay package. Final selection, methods, sample requirements and reporting will be confirmed with Apollo before testing. Identity testing may overlap with ESI-MS; stability is a separate, time-based study.
Identity02
Identity testing
Confirmation of the submitted compound's identity. The agreed method may overlap with ESI mass spectrometry; these are not automatically two independent assays.
Contaminants03
Endotoxins (LAL)
Testing for bacterial endotoxins using a limulus amebocyte lysate assay. This does not establish sterility.
Elemental impurities04
Heavy metals
An ICP-MS panel for selected elemental contaminants. The elements, reporting limits and specifications will be defined by the laboratory.
Microbiology05
Total yeast & mold
Testing for yeast and mold in the submitted sample. This is not a full sterility test or a screen for every microorganism.
Characterization06
ESI mass spectrometry
Mass-spectrometric characterization to support molecular-mass and identity assessment. Reported detail depends on the method ordered.
Composition07
Amino acid analysis
Analysis of amino acid composition for applicable peptide samples. Applicability and reporting are compound-specific.
Quantity08
Potency / quantity
Measurement of the amount or concentration of the target compound. A quantity result is separate from HPLC purity and is not evidence of clinical efficacy.
Stability09
ICH stability study
A time-based study under agreed storage conditions, such as accelerated or real-time stability. A separate study protocol and timeline are required.
Results apply only to the submitted samples and the scope stated in each report. This announcement does not mean current inventory has completed nine-panel testing. Analytical testing does not establish suitability for human or veterinary use.
Available now
Review current reports
Browse published laboratory sample results below.
Coming next
Confirm the expanded scope
Finalize the applicable assays and stability-study protocol with Apollo.
As reports arrive
Publish sample-specific results
Add the laboratory reports and identify the products and lots they cover.
Available reports
Current Certificates of Analysis
Purity and net content are separate measurements, reproduced from the posted reports. Results apply to the submitted samples—not automatically every vial or current inventory. Match the report to your sample or lot; contact us if the listed identifier is insufficient.
Open Freedom Diagnostics COA lookup15 of 15 product entries
Product
Reported purity
Reported net content
Report & verification
Reported purity
99.48%
HPLC · posted sample
Reported net content
8.39 mg
Reported purity
99.50%
HPLC · posted sample
Reported net content
BPC-157 10.83 mg / TB-500 12.64 mg
Reported purity
99.77%
HPLC · posted sample
Reported net content
18.68 mg
Reported purity
99.66%
HPLC · posted sample
Reported net content
76.24 mg
Reported purity
99.53%
HPLC · posted sample
Reported net content
1071.55 mg
Reported purity
99.25%
HPLC · posted sample
Reported net content
6.13 mg
Reported purity
99.11%
HPLC · posted sample
Reported net content
9.83 mg
Reported purity
99.89%
HPLC · posted sample
Reported net content
0.90%
Reported purity
99.68%
HPLC · posted sample
Reported net content
9.02 mg
Reported purity
99.93%
HPLC · posted sample
Reported net content
8.01 mg
Reported purity
99.31%
HPLC · posted sample
Reported net content
11.06 mg
Reported purity
99.51%
HPLC · posted sample
Reported net content
31.64 mg
KLOW 80mg
Report authentication code (not a manufacturing lot): KLOW80-20260928S3413
Reported: September 28, 2026
Reported purity
99.99% (combination purity)
HPLC · posted sample
Reported net content
GHK-Cu 55.36 mg / KPV 11.69 mg / TB-500 10.54 mg / BPC-157 12.06 mg
View sample COA Laboratory verification / website
TJQXGD (third-party partner laboratory data)
Search code: KLOW80-20260928S3413
Reported purity
99.96%
HPLC · posted sample
Reported net content
GHK-Cu 50.82 mg / TB-500 10.33 mg / BPC-157 10.52 mg
Reported purity
99.80%
HPLC · posted sample
Reported net content
BPC-157 5.82 mg / Thymosin Beta-4 6.63 mg
To verify a report, use its listed code and issuing laboratory's website or contact details. Apollo's COA verification service is for Apollo-issued reports; it does not verify the other laboratories' documents.